Article Versions Notes

Scarabel L, Polesel J, De Mattia E, Buonadonna A, D'Andrea MR, Cecchin E, Toffoli G. Association of HLA-G 3′UTR Polymorphisms with Response to First-Line FOLFIRI Treatment in Metastatic Colorectal Cancer. Pharmaceutics. 2022; 14(12):2737. https://doi.org/10.3390/pharmaceutics14122737

Scarabel, Lucia, Jerry Polesel, Elena De Mattia, Angela Buonadonna, Mario Rosario D'Andrea, Erika Cecchin, and Giuseppe Toffoli. 2022. "Association of HLA-G 3′UTR Polymorphisms with Response to First-Line FOLFIRI Treatment in Metastatic Colorectal Cancer" Pharmaceutics 14, no. 12: 2737. https://doi.org/10.3390/pharmaceutics14122737

Scarabel, L., Polesel, J., De Mattia, E., Buonadonna, A., D'Andrea, M. R., Cecchin, E., & Toffoli, G. (2022). Association of HLA-G 3′UTR Polymorphisms with Response to First-Line FOLFIRI Treatment in Metastatic Colorectal Cancer. Pharmaceutics, 14(12), 2737. https://doi.org/10.3390/pharmaceutics14122737